The Enterprise Value as of November 2024 (TTM) for Cardiff Oncology, Inc. (CRDF) is 113.93M

According to Cardiff Oncology, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 113.93M. This represents a change of -2.62% compared to the average of 116.99M of the last 4 quarters.

Cardiff Oncology, Inc. (CRDF) Historical Enterprise Value (quarterly & annually)

How has CRDF Enterprise Value performed in the past?

The mean historical Enterprise Value of Cardiff Oncology, Inc. over the last ten years is 76.54M. The current 113.93M Enterprise Value has changed 14.78% with respect to the historical average. Over the past ten years (40 quarters), CRDF's Enterprise Value was at its highest in in the March 2021 quarter at 330.12M. The Enterprise Value was at its lowest in in the June 2018 quarter at -12769882.72.

Cardiff Oncology, Inc. (CRDF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Cardiff Oncology, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cardiff Oncology, Inc. (CRDF) Average Enterprise Value

How has CRDF Enterprise Value performed in the past?

The current Enterprise Value of Cardiff Oncology, Inc. (CRDF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Cardiff Oncology, Inc. (CRDF) Enterprise Value vs. Peers

How is CRDF’s Enterprise Value compared to its peers?

Cardiff Oncology, Inc.’s Enterprise Value is greater than Reviva Pharmaceuticals Holdings, Inc. (33.37M), greater than eFFECTOR Therapeutics, Inc. (4.74M), greater than PDS Biotechnology Corporation (53.10M), greater than Navidea Biopharmaceuticals, Inc. (-2504975.00), greater than Reviva Pharmaceuticals Holdings, Inc. (33.37M), greater than Eyenovia, Inc. (15.12M), greater than Cognition Therapeutics, Inc. (-3660922.00), greater than TransCode Therapeutics, Inc. (4.92M), less than Kodiak Sciences Inc. (201.31M), greater than SELLAS Life Sciences Group, Inc. (61.79M), greater than NLS Pharmaceutics AG (9.64M), less than Mereo BioPharma Group plc (496.22M), greater than Aravive, Inc. (-3158140.00), less than Day One Biopharmaceuticals, Inc. (963.46M), greater than IN8bio, Inc. (24.49M), greater than Cue Biopharma, Inc. (41.71M), greater than Lantern Pharma Inc. (25.41M), less than Gracell Biotechnologies Inc. (5.61B), less than Cullinan Oncology, Inc. (630.54M), greater than Bolt Biotherapeutics, Inc. (30.96M), greater than Lyra Therapeutics, Inc. (23.90M), less than Autolus Therapeutics plc (177.55M),

Build a custom stock screener for Cardiff Oncology, Inc. (CRDF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cardiff Oncology, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cardiff Oncology, Inc. (CRDF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cardiff Oncology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.